ALFUGRESS TAB 10

About

Alfugress Tab contains Alfuzosin, an alpha-1 adrenergic antagonist primarily used to treat the symptoms of benign prostatic hyperplasia (BPH). It works by selectively blocking alpha-1 receptors located in the prostate, bladder neck, and urethra. This action leads to the relaxation of smooth muscles in these areas, which in turn reduces the resistance to urine flow and alleviates obstructive symptoms associated with BPH. Alfuzosin helps improve urinary flow rate and reduces symptoms such as urinary hesitancy, weak stream, and incomplete bladder emptying. Its extended-release formulation allows for once-daily dosing, providing sustained symptom relief throughout the day.

The medication is designed to target the dynamic component of BPH, which is the increased smooth muscle tone in the prostate and bladder neck. By relaxing these muscles, Alfugress helps to open up the urinary channel, making urination easier and more comfortable for men with BPH. It is important to take this medication as prescribed by a healthcare professional to achieve optimal therapeutic benefits and minimize potential side effects.

Uses

• Relief of symptoms of benign prostatic hyperplasia (BPH)
• Improvement of urinary flow in men with BPH
• Reduction of urinary hesitancy and weak stream
• Alleviation of nocturia and urinary urgency associated with BPH

Directions For Use

Take orally, once daily, immediately after a meal. Swallow the tablet whole; do not crush, chew, or break it.

Benefits

• Improves urinary flow rate significantly
• Reduces symptoms of urinary urgency and frequency
• Alleviates discomfort from incomplete bladder emptying
• Provides sustained relief with once-daily dosing
• Helps reduce the need for frequent nighttime urination
• Generally well-tolerated in long-term use

Side Effects

• Dizziness
• Postural hypotension
• Headache
• Fatigue
• Nausea
• Abdominal pain
• Rhinitis
• Asthenia
• Somnolence
• Blurred vision
• Priapism (rare)
• Syncope

Safety Measures

• Alcohol - Alcohol may enhance the hypotensive effects of Alfuzosin, increasing the risk of dizziness and fainting. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - Alfuzosin is not indicated for use in women.
• Breastfeeding - Alfuzosin is not indicated for use in women.
• Liver - Use with caution in patients with mild to moderate hepatic impairment; dose adjustment may be necessary. Contraindicated in severe hepatic impairment.
• Kidney - Use with caution in patients with severe renal impairment (CrCl < 30 mL/min); dose adjustment may be considered.
• Lung - Generally safe for use in patients with lung conditions, but caution is advised if there's a risk of syncope that could exacerbate a pre-existing respiratory issue.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.